Australia: Excessive caffeine consumption could increase renal calcium clearance in healthy patients by 77% which in turn could contribute to osteoporosis, reveals a recent study by researchers from the University of South Australia. The study assessed the impact of high-dose, short-term caffeine consumption.
The study results, published in the British Journal of Clinical Pharmacology, present a warning related to overconsumption of coffee and other caffeinated beverages even among healthy people.
Previous studies have shown caffeine consumption to be associated with osteoporosis due to enhanced bone resorption as a result of increased excretion of calcium in the urine. However, calcium amount in the urine may not necessaritly reflect the true effect of caffeine on calcium clearance. Considering the same, Stephanie E. Reuter, UniSA Clinical & Health Sciences, University of South Australia, Adelaide, SA, Australia, and colleagues aimed to examine the impact of high-dose, short-term caffeine intake on renal clearance of calcium, sodium and creatinine in healthy adults in this double-blind clinical study.
Also Read: Surgical caffeine does not reduce early postoperative opioid consumption: Study
The participants were made to chew caffeine (n=12) or placebo (n=12) gum for 5 minutes at an interval of 2-hours over a 6-hour treatment period (800 mg total caffeine).
They fund that caffeine increased renal calcium clearance by 77%. Furthermore, the effect was positively correlated with sodium clearance and urine volume. This suggests that caffeine may act through inhibition of sodium reabsorption in the proximal convoluted tubule.
"This study confirmed that caffeine does increase renal calcium clearance and fosters further investigation into safe consumption of caffeine," concluded the authors.
Also Read: Excess coffee consumption may increase risk of dementia, finds new research
Reference:
The study titled, "The effect of high-dose, short-term caffeine intake on the renal clearance of calcium, sodium and creatinine in healthy adults," is published in the British Journal of Clinical Pharmacology.
DOI: https://bpspubs.onlinelibrary.wiley.com/doi/10.1111/bcp.14856